Essex Bio-Technology Limited reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was HKD 1,706.56 million compared to HKD 1,317.71 million a year ago. Net income was HKD 275.26 million compared to HKD 225.41 million a year ago.

Basic earnings per share from continuing operations was HKD 0.4827 compared to HKD 0.3927 a year ago. Diluted earnings per share from continuing operations was HKD 0.469 compared to HKD 0.3828 a year ago.